|
|
|
Article Cited by others ORIGINAL ARTICLE
Quinalizarin, a specific CK2 inhibitor, reduces cell viability and suppresses migration and accelerates apoptosis in different human lung cancer cell lines
Zhou Y, Li K, Zhang S, Li Q, Li Z, Zhou F, Dong X, Liu L, Wu G, Meng R
Year : 2015| Volume: 52| Issue : 6 | Page no: 119-124 | This article has been cited by | | 1 |
Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT-4 and HCT 116 Cells |
|
| | Sayantani Mukherjee Chatterjee,Chetan Kumar Jain,Soumen Singha,Piyal Das,Susanta Roychoudhury,Hemanta Kumar Majumder,Saurabh Das | | | ACS Omega. 2018; 3(8): 10255 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target |
|
| | Melissa Chua,Charina Ortega,Ayesha Sheikh,Migi Lee,Hussein Abdul-Rassoul,Kevan Hartshorn,Isabel Dominguez | | | Pharmaceuticals. 2017; 10(4): 18 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Association of protein kinase CK2 inhibition with cellular radiosensitivity of non-small cell lung cancer |
|
| | Qianwen Li,Ke Li,Tianyang Yang,Sheng Zhang,Yu Zhou,Zhenyu Li,Jinrong Xiong,Fangzheng Zhou,Xiaoshu Zhou,Li Liu,Rui Meng,Gang Wu | | | Scientific Reports. 2017; 7(1) | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
